Comparison of the diagnostic yield of transbronchial lung biopsies by forceps and cryoprobe in diffuse parenchymal lung disease
Article Sidebar
Main Article Content
Abstract
Background. Transbronchial lung cryobiopsy (TBLC) in the diagnosis of diffuse parenchymal lung disease (DPLD) has shown a promising yield in recent times, with low post-procedural mortality and morbidity.
Objectives. To compare the yield of TBLC and conventional transbronchial forceps lung biopsy (TBLB).
Methods. A prospective study was carried out in patients with DPLD over a period of 1 year in a tertiary respiratory care institute in New Delhi, India. All 87 patients enrolled underwent both TBLB and TBLC. The procedures were performed in the bronchoscopy suite under conscious sedation and local anaesthesia, with an attempt to take a minimum of three biopsy specimens by conventional TBLB followed by TBLC. A 1.9 mm cryoprobe with a freezing time of 4 - 5 seconds was used. An Arndt endobronchial blocker was used to control bleeding along with locally administered medications.
Results. TBLB and TBLC led to a definitive diagnosis in 27 (31.0%) and 69 (79.3%) cases, respectively. The commonest diagnoses were hypersensitivity pneumonitis, sarcoidosis and pulmonary tuberculosis. TBLC led to additional diagnoses in 42 cases (48.3%). Pneumothorax was observed in 12 cases (13.8%), and moderate bleeding occurred in 63 (72.4%). There were no procedure-related deaths.
Conclusion. TBLC had a better diagnostic yield than conventional TBLB in DPLD. It has the potential to become a safe day-care procedure in a resource-limited setting, if certain precautions are taken.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The AJTCCM is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
Singh V, Sharma BB. Laying the ground for research of interstitial lung disease in our country: ILD India registry. Lung India 2014;31(4):320-322. https://doi. org/10.4103/0970-2113.142091
Maher TM. A clinical approach to diffuse parenchymal lung disease. Immunol Allergy Clin North Am 2012;32(4):453-472. https://doi.org/10.1016/j.iac.2012.08.004
Deconinck B, Verschakelen J, Coolen J, Verbeken E, Verleden G, Wuyts W. Diagnostic workup for diffuse parenchymal lung disease: Schematic flowchart, literature review, and pitfalls. Lung 2013;191(1):19-25. https://doi.org/10.1007/s00408-012-9433-5
Ravaglia C, Bonifazi M, Wells AU, et al. Safety and diagnostic yield of transbronchial lung cryobiopsy in diffuse parenchymal lung diseases: A comparative study versus video-assisted thoracoscopic lung biopsy and a systematic review of the literature. Respiration 2016;91(3):215-227. https://doi.org/10.1159/000444089
Du Rand IA, Blaikley J, Booton R, et al. British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: Accredited by NICE. Thorax 2013;68 (Suppl 1):i1-i44. https://doi.org/10.1136/thoraxjnl-2013-203618
Ravaglia C, Wells AU, Tomassetti S, et al. Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: A large cohort of 699 patients. BMC Pulm Med 2019;19(1):16. https://doi.org/10.1186/ s12890-019-0780-3
Wälscher J, Groß B, Eberhardt R, et al. Transbronchial cryobiopsies for diagnosing interstitial lung disease: Real-life experience from a tertiary referral center for interstitial lung disease. Respiration 2019;97(4):348-354. https://doi.org/10.1159/000493428
Kropski JA, Pritchett JM, Mason WR, et al. Bronchoscopic cryobiopsy for the diagnosis of diffuse parenchymal lung disease. PLoS ONE 2013;8(11):e78674. https:// doi.org/10.1371/journal.pone.0078674
Du Bois RM, Richeldi L. Interstitial Lung Diseases. Lausanne, Switzerland: European Respiratory Society, 2009:46. https://doi.org/10.1183/1025448x.ERM4609
Raghu G, Mehta S. Interstitial lung disease (ILD) in India: Insights and lessons from the prospective, landmark ILD-India registry. Lung India 2016;33(6):589-591. https:// doi.org/10.4103/0970-2113.192874
Pajares V, Núñez-Delgado M, Bonet G, et al. Transbronchial biopsy results according to diffuse interstitial lung disease classification: Cryobiopsy versus forceps: MULTICRIO study. PLoS ONE 2020;15(9):e0239114. https://doi.org/10.1371/journal.pone.0239114
Johannson KA, Marcoux VS, Ronksley PE, Ryerson CJ. Diagnostic yield and complications of transbronchial lung cryobiopsy for interstitial lung disease: A systematic review and metaanalysis. Ann Am Thorac Soc 2016;13(10):1828-1838. https://doi.org/10.1513/AnnalsATS.201606-461SR